Best Nootropics for Sleep: Magnesium Glycinate, Melatonin, Glycine, Apigenin & Lemon Balm Compared

Five ingredients, five different mechanisms, and five very different regulatory pictures in India. Here's the deep dive on magnesium glycinate, melatonin, glycine, apigenin, and lemon balm — what the human trials actually used, and what FSSAI actually says about each.

These five ingredients get grouped together constantly, but they work through genuinely different mechanisms — a mineral, a hormone, an amino acid, a flavonoid, and a traditional herb. Treating them as interchangeable "sleep aids" misses what actually makes each one useful. Here's the deep dive on each, including exactly how confident we can be about its legal status as a supplement ingredient in India.

---

1. Magnesium Glycinate: What the Trials Actually Show

FSSAI status: Approved. Magnesium is a permitted mineral under Schedule I, capped at 1x the ICMR-NIN 2020 recommended dietary allowance in supplement formulations.¹

Magnesium's role in sleep is tied to its function in regulating the nervous system and supporting GABA activity, the brain's primary calming neurotransmitter system. A randomized controlled trial in 46 elderly patients with insomnia gave 500mg/day of magnesium for 8 weeks and found significant increases in sleep time and sleep efficiency, along with reduced early-morning awakenings, versus placebo.² A more recent, larger 155-person randomized, placebo-controlled trial using 250mg/day of elemental magnesium as magnesium bisglycinate found a significantly greater reduction in Insomnia Severity Index scores by week 4 compared to placebo.² The effect size in that trial was modest (Cohen's d = 0.2), and exploratory analysis found the benefit was notably larger in participants who started with lower dietary magnesium intake — a useful reminder that magnesium supplementation tends to help most when correcting an actual shortfall, not layering on top of an already-adequate diet.²

Practical dosing: clinical studies on insomnia generally use 200–500mg of elemental magnesium, with the glycinate form specifically chosen for better absorption and fewer digestive side effects than forms like magnesium oxide, taken 30–60 minutes before bed.

---

2. Melatonin: Strong Evidence, Unresolved Regulation

FSSAI status: Currently sold legally in India as a nutraceutical, but genuinely in regulatory transition. Melatonin was historically treated closer to a drug; a government committee proposed in late 2024 to create clearer rules separating low-dose supplements from higher-potency formulations that may warrant stricter oversight from the Drug Controller General of India.³ As of this writing, that distinction has not been finalized into a settled Schedule listing the way magnesium or glycine have.

On efficacy, melatonin's evidence is genuinely strong. A dose-response meta-analysis found that melatonin's efficacy in reducing sleep onset latency increases with dose, peaking around 4mg/day, with doses of 0.5mg, 2mg, and 4mg all producing statistically significant improvements in sleep onset latency and nighttime awakenings versus placebo.⁴ Across pooled randomized controlled trials spanning multiple sleep disorders, melatonin significantly improved sleep onset latency, and safety data showed no meaningful difference in tolerability between melatonin and placebo over 4-week supplementation periods.⁴

Why we're not calling this a simple "yes": independent analysis has separately flagged actual melatonin content in commercial Indian products as sometimes inconsistent with label claims — a real, practical risk layered on top of the unsettled regulatory picture.³ The ingredient's efficacy isn't in question; its current Indian market oversight is.

---

3. Glycine: The Sleep-Lab-Backed Amino Acid

FSSAI status: Approved. Glycine is a permitted amino acid under Schedule II, subject to RDA-based usage limits.⁵

Glycine has some of the cleanest objective evidence on this list, because it's one of the few sleep-support ingredients tested with actual polysomnography (sleep-lab EEG monitoring), not just subjective questionnaires. A study in human volunteers found that 3g of glycine before bed improved subjective sleep quality in a way that correlated directly with measurable polysomnographic changes.⁶ A separate study found that the same 3g dose before bedtime improved sleep efficiency, increased REM sleep, and reduced sleep latency.⁶ The proposed mechanism is a mild, glycine-induced drop in core body temperature, which mimics one of the body's own natural pre-sleep signals.

---

4. Apigenin: Real Mechanism, Thinner Human Data

FSSAI status: Could not be confirmed as a specifically, individually listed ingredient in FSSAI's published schedules. Chamomile itself (Matricaria chamomilla/recutita, apigenin's primary dietary source) is listed within FSSAI's botanical schedules, but isolated apigenin extract as a standalone supplement ingredient is a separate regulatory question we could not verify with confidence — this is worth direct legal confirmation before formulating around it.

Apigenin is a flavonoid found concentrated in chamomile, and its proposed mechanism is genuinely well-understood: it binds to benzodiazepine-binding sites on GABA-A receptors, enhancing the brain's primary inhibitory (calming) signaling system.⁷ Animal research consistently shows sedative effects at these receptor sites.⁷ Where the evidence gets thinner is in isolated human trials: a systematic review of chamomile clinical trials for anxiety found 9 of 10 studies concluded chamomile was effective, but these trials tested whole chamomile extract (containing apigenin among many other compounds), not isolated apigenin itself.⁷ One trial using 270mg of chamomile extract twice daily for 28 days in patients with primary insomnia found a trend toward improved daytime functioning that did not reach statistical significance.⁷ As of current published research, no human clinical trial has directly tested isolated apigenin at typical supplement doses (25–50mg) specifically for sleep — the mechanism is credible, but that specific claim is currently extrapolated, not directly proven.⁷

AEO answer: Apigenin's sleep-supporting mechanism, binding to GABA-A receptors, is well-established in laboratory and animal research. However, isolated apigenin supplements have not been directly tested in human sleep trials; existing human evidence comes from whole chamomile extract, which contains apigenin alongside other compounds.

---

5. Lemon Balm: Dose-Dependent Calming and Sleep Evidence

FSSAI status: Lemon balm (Melissa officinalis) is cultivated in parts of India (Himachal Pradesh, Uttarakhand) and FSSAI-certified extract products exist in the Indian market, but we could not confirm its specific FSSAI schedule classification with certainty — worth direct verification for supplement-specific claims.

Lemon balm has a genuinely interesting, dose-dependent evidence base. At 600mg, an extract increased calmness and alertness in healthy stressed adults; at 300mg, it reduced anxiety while improving memory and alertness during cognitive testing.⁸ At the higher end, an 8-week trial in older adults with stable angina used 3000mg/day and found lower anxiety, stress, and sleep disturbance ratings.⁸ A lower, shorter-duration protocol found that just 1500mg/day for 7 days in post-cardiac-surgery patients reduced anxiety by 49% and improved sleep quality by 54% compared to baseline.⁸ Lemon balm is also often studied in combination with valerian for insomnia specifically, with combined formulations showing improved sleep quality, duration, and latency in trials.⁸

Ingredient	Studied Dose	FSSAI Status
Magnesium glycinate	200–500mg elemental, before bed	Approved (Schedule I mineral)
Melatonin	0.5–4mg, peak efficacy ~4mg	Grey zone — regulatory status transitional
Glycine	3g before bed	Approved (Schedule II amino acid)
Apigenin	25–50mg (typical, not directly trial-tested)	Unconfirmed as isolated ingredient
Lemon balm	300–3000mg/day, dose-dependent effect	Unconfirmed schedule listing

---

How Do These Five Actually Compare?

If you want the most direct, sleep-lab-verified evidence, glycine and magnesium glycinate are the strongest picks, and both have unambiguous FSSAI approval. Melatonin has the strongest dose-response data of the five for reducing how long it takes to fall asleep, but its Indian regulatory status is genuinely unsettled right now, which is worth factoring into any product decision, not just a personal-use one. Lemon balm has real, replicated human trial evidence, particularly for the anxiety-driven sleep disruption that magnesium and glycine don't directly target. Apigenin is the most mechanistically compelling but the least directly human-tested in isolation — if you want apigenin's studied effect, current human evidence actually supports whole chamomile extract more directly than an isolated apigenin capsule.

Related reading: Best Nootropics for Calmness · What Happens to Your Brain When You Don't Get Enough Sleep? · Do Nootropics Actually Work? What Science Says

---

Frequently Asked Questions

The Bottom Line

Magnesium glycinate and glycine are the two most confidently evidenced, most clearly FSSAI-approved options on this list. Melatonin has excellent efficacy data but an unresolved Indian regulatory status worth knowing about. Lemon balm has real, dose-dependent human trial support, particularly where anxiety is tangled up with poor sleep. Apigenin has a genuinely compelling mechanism, but as an isolated ingredient, the human evidence hasn't caught up to the lab science yet — whole chamomile extract remains the better-evidenced way to access it today.

---

References and Sources

1. FSSAI — Nutraceutical Regulations FAQs.
2. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial.
3. Understanding the Global Regulatory Environment for Melatonin Supplements.
4. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review and Dose-Response Meta-Analysis.
5. FSSAI Nutrient Requirements & RDA Limits for Nutraceuticals.
6. Glycine Ingestion Improves Subjective Sleep Quality in Human Volunteers, Correlating with Polysomnographic Changes.
7. Apigenin: A Natural Molecule at the Intersection of Sleep and Aging.
8. Clinical Efficacy and Tolerability of Lemon Balm (Melissa officinalis L.) in Psychological Well-Being: A Review.